Review

Venous thromboembolism: What to do after anticoagulation is started

Scott Kaatz, DO, MSc, FACP, Waqas Qureshi, MD and Robert C. Lavender, MD, FACP
Cleveland Clinic Journal of Medicine September 2011, 78 (9) 609-618; DOI: https://doi.org/10.3949/ccjm.78a.10175

ABSTRACT

After anticoagulation has been started in patients with venous thromboembolism (VTE), three issues need to be addressed: the length of therapy, measures to help prevent postthrombotic syndrome, and a basic workup for malignancy in patients with idiopathic VTE.

Footnotes

  • ↵a Dr. Kaatz has disclosed consulting, teaching and speaking, independent contracting (including contracted research), and membership on advisory committees or review panels for the Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Ortho-McNeil, and Johnson and Johnson corporations.

  • ↵b Dr. Lavender has disclosed receiving research support for clinical trials from the Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, and Daiichi Sankyo corporations.

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section